- Previous Close
14.72 - Open
14.70 - Bid 14.29 x --
- Ask 14.30 x --
- Day's Range
14.28 - 14.82 - 52 Week Range
14.28 - 30.22 - Volume
12,630,249 - Avg. Volume
8,480,647 - Market Cap (intraday)
16.286B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
16.63 - EPS (TTM)
0.86 - Earnings Date --
- Forward Dividend & Yield 0.31 (2.17%)
- Ex-Dividend Date Jun 21, 2024
- 1y Target Est
31.43
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
www.dslyy.comRecent News: 603233.SS
View MorePerformance Overview: 603233.SS
Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603233.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603233.SS
View MoreValuation Measures
Market Cap
16.29B
Enterprise Value
17.70B
Trailing P/E
16.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
2.23
Enterprise Value/Revenue
0.70
Enterprise Value/EBITDA
11.14
Financial Highlights
Profitability and Income Statement
Profit Margin
4.22%
Return on Assets (ttm)
4.50%
Return on Equity (ttm)
14.46%
Revenue (ttm)
25.34B
Net Income Avi to Common (ttm)
1.07B
Diluted EPS (ttm)
0.86
Balance Sheet and Cash Flow
Total Cash (mrq)
5.4B
Total Debt/Equity (mrq)
80.51%
Levered Free Cash Flow (ttm)
3.17B